In this Healio Video Perspective, Dante J. Pieramici, MD, discusses a trial investigating contrast sensitivity as a visual ...

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

Diabetic retinopathy is a leading cause of vision loss in working-age Indians. Doctor stresses that tight diabetes control, regular eye exams, and timely treatment can help protect sight from this ...

For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy.

For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy.

Definitive conclusions regarding the association between semaglutide and nonarteritic anterior ischemic optic neuropathy ...

Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to ...

Recently, second-generation anti-VEGF agents, including brolucizumab, faricimab, and 8 mg aflibercept, have become available ...

Health experts convened on August 21 to explore the development of a comprehensive management model for patients with ...

Palatin has a research program in DR, and more specifically, in diabetic macular edema (DME), a complication of DR that ...